GLP-1 / Metabolic

Survodutide

Survodutide (BI 456906)

GLP-1/glucagon dual agonist by Boehringer Ingelheim. NASH and obesity trials.

Typical dose

2.4–6 mg

Frequency

Once weekly

Half-life

—

Route

subcutaneous

Typical vial sizes

5 mg

Sample reconstitution

5 mg vial · 2 mL bac water · 4.2 mg dose

Draw volume: 1.680 mL
Insulin units: 168 units
Concentration: 2.50 mg/mL
Doses per vial: 1.2

Open full calculator →

Research use only.

Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.